Cargando…

Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis

BACKGROUND: The prothrombotic defect factor V Leiden (FVL) may confer higher risk of ST‐segment–elevation myocardial infarction (STEMI), compared with non–ST‐segment–elevation acute coronary syndrome, and may be associated with more myocardial necrosis caused by higher thrombotic burden. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmoodi, Bakhtawar K., Eriksson, Niclas, Vos, Gerrit J. A., Meijer, Karina, Siegbahn, Agneta, James, Stefan, Wallentin, Lars, ten Berg, Jurriën M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483522/ https://www.ncbi.nlm.nih.gov/pubmed/33998271 http://dx.doi.org/10.1161/JAHA.120.020025

Ejemplares similares

Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials
por: Mahmoodi, Bakhtawar K., et al.
Publicado: (2021)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome
por: Johansson, Åsa, et al.
Publicado: (2015)

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
por: Siegbahn, Agneta, et al.
Publicado: (2023)

Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
por: Batra, Gorav, et al.
Publicado: (2022)

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
por: Attelind, Sofia, et al.
Publicado: (2022)

Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice
por: Schilperoort, Maaike, et al.
Publicado: (2020)

Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐Analysis
por: Brouwer, Jorn, et al.
Publicado: (2021)

Charcot-Leiden Crystals in Acute Myeloid Leukemia with Bone Marrow Necrosis
por: Yeldir, Neşe, et al.
Publicado: (2023)

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
por: Wallentin, Lars, et al.
Publicado: (2021)

Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
por: Wallentin, Lars, et al.
Publicado: (2013)

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients
por: Christersson, Christina, et al.
Publicado: (2017)

Skin Necrosis in a Patient with Factor V Leiden Mutation following Nipple Sparing Mastectomy
por: Bingol, Ugur Anil, et al.
Publicado: (2015)

Wolfgang Pauli in Leiden
por: Unknown
Publicado: (1953)

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008)

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
por: Sumaya, Wael, et al.
Publicado: (2020)

Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial
por: Hjort, Marcus, et al.
Publicado: (2022)

Does the extent of collaterals influence the severity of the myocardial injury as assessed by elevation in biomarkers?
por: Dubey, Gajendra, et al.
Publicado: (2021)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Apples in Amsterdam and oranges in Leiden
por: Koster, R. W.
Publicado: (2014)

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
por: Sumaya, Wael, et al.
Publicado: (2018)

Testing differences statistically with the Leiden ranking
por: Leydesdorff, Loet, et al.
Publicado: (2012)

Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice
por: Seidel, Florine, et al.
Publicado: (2022)

Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life
por: Wallentin, Lars
Publicado: (2018)

Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer
por: Eriksson, Oskar, et al.
Publicado: (2016)

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
por: Varenhorst, Christoph, et al.
Publicado: (2009)

Leiden University in the seventeenth century. An exchange of learning
Publicado: (1976)

Homocysteine and Familial Longevity: The Leiden Longevity Study
por: Wijsman, Carolien A., et al.
Publicado: (2011)

The relationship between FV Leiden and pulmonary embolism
por: Hooper, W Craig, et al.
Publicado: (2002)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
por: Sjölin, Karl, et al.
Publicado: (2022)

Prevalence and Extent of Subclinical Atherosclerosis and Associated Cardiovascular Risk Factors in Adult Patients With Psoriatic Arthritis: A Systematic Review
por: Jamil, Maria, et al.
Publicado: (2021)

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
por: Edén, Desirée, et al.
Publicado: (2019)

Effects on cardiac function, remodeling and inflammation following myocardial ischemia–reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice
por: Pluijmert, Niek J., et al.
Publicado: (2020)

The Leiden Convention coronary coding system: translation from the surgical to the universal view
por: Koppel, Claire J, et al.
Publicado: (2021)

Electrocardiographic markers of myocardial infarction size, transmural extent, and extent of nonviable myocardium - comparison to CMR
por: Lee, Daniel C, et al.
Publicado: (2016)

Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults
por: Kheradmand, Ehsan, et al.
Publicado: (2014)

The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice
por: Hoving, Lisa R., et al.
Publicado: (2018)

Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma
por: O'Malley, Thomas J., et al.
Publicado: (2017)

From Louvain to Leiden: guaranteeing well-connected communities
por: Traag, V. A., et al.
Publicado: (2019)

Factor V Leiden interferes with protein S activity assay
por: Panaget, Baptiste, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fu70666i0hacmb35sv2nblgsrp